|
End-of-day quote
Nasdaq
2026-10-20
|
5-day change | 1st Jan Change | ||
| 1.670 USD | +5.70% |
|
0.00% | -81.51% |
| 10-15 | EnGene Therapeutics Inc. - Special Call | |
| 09-20 | EnGene Therapeutics Inc.(NasdaqCM:ENGN) dropped from S&P Global BMI Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ENGENE THERAPEUTICS INC. | Bio Therapeutic Drugs | +5.70% | 0.00% | -81.51% | -79.79% | - | 105M |  | | |
- Stock Market
- Stocks
- ENGN Stock
- Charts enGene Therapeutics Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
